ArticleFrontiers in cell and developmental biology2021

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature.

Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.